MedNation AG (Frankfurt:EIF.F)
| Market Cap | 11.23M+38.9% |
| Revenue (ttm) | 54.82M |
| Net Income | 2.52M |
| EPS | 1.08 |
| Shares Out | 2.81M |
| PE Ratio | 3.70 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Jul 12, 2017 |
| Volume | 20 |
| Open | 4.00 |
| Previous Close | 4.00 |
| Day's Range | 4.00 - 4.00 |
| 52-Week Range | 2.50 - 4.50 |
| Beta | n/a |
| Analysts | none |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About EIF.F
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eifelhöhen-Klinik AG. MedNation AG was founded in 1970 and is based in Bonn, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$EIF.F stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in EIF.F holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EIF.F's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EIF.F Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New EIF.F patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EIF.F from public contracts
Source: USAspending.gov
EIF.F Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EIF.F’s recent data — informational, not investment advice